REQUEST A DEMO
Total
USD $0.00
Search more companies

Mediterra Tecnologia Biomedica S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mediterra Tecnologia Biomedica S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Mediterra Tecnologia Biomedica S.A.S. is based in Ecuador, with the head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on November 08, 2022. The total number of employees is currently 10 (2024). The latest financial highlights indicate a net sales revenue drop of 12.86% in 2024. Over the same period, its total assets decreased by 67.96%.

Headquarters
Av. de la Prensa, N58 243
Quito; Pichincha;

Contact Details: Purchase the Mediterra Tecnologia Biomedica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Mediterra Tecnologia Biomedica S.A.S. report to view the information.
Registered Capital:
Purchase the Mediterra Tecnologia Biomedica S.A.S. report to view the information.
Financial Auditors:
Purchase the Mediterra Tecnologia Biomedica S.A.S. report to view the information.
Incorporation Date:
November 08, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Mediterra Tecnologia Biomedica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-12.86%
Total operating revenue
-12.86%
Operating profit (EBIT)
23.59%
EBITDA
24.8%
Net Profit (Loss) for the Period
N/A
Total Assets
-67.96%
Total Equity
74.49%
Operating Profit Margin (ROS)
2.86%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
65.32%
Quick Ratio
0.68%
Cash Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?